---
schema_version: "secwatch.filing_event.v1"
accession: "0001549595-26-000028"
form_type: "8-K"
ticker: "NRIX"
cik: "0001549595"
company_name: "Nurix Therapeutics, Inc."
filed_at: "2026-05-15T20:03:04+00:00"
generated_at: "2026-05-15T20:08:59.216053+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.2
calibrated_materiality_score: 0.15
confidence: "high"
source: SEC EDGAR
---

# Nurix Therapeutics 2026 annual meeting votes: directors elected, auditor ratified, say-on-pay approved

## Summary
- Elected all three Class III director nominees: Arthur T. Sands (63.6M for, 16.3M withheld), Roger Dansey (79.6M for, 0.3M withheld), Paul M. Silva (59.3M for, 20.6M withheld).
- Ratified PricewaterhouseCoopers LLP as independent auditor for FY2026 with 83.6M for, 0.2M against, 0.02M abstentions.
- Approved non-binding advisory vote on named executive officer compensation: 72.5M for, 6.9M against, 0.6M abstentions, 3.8M broker non-votes.
- Approximately 81% of voting power (83.7M shares) present, establishing a quorum.

## SEC filing metadata
- accession: 0001549595-26-000028
- form_type: 8-K
- ticker: NRIX
- cik: 0001549595
- company_name: Nurix Therapeutics, Inc.
- filed_at: 2026-05-15T20:03:04+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.2
- calibrated_materiality_score: 0.15
- confidence: high
- sec_items: 5.07, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1549595/000154959526000028/0001549595-26-000028-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1549595/000154959526000028/nrix-20260515.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001549595-26-000028
- JSON: https://secwatch.observer/filing/0001549595-26-000028.json
- Plain text: https://secwatch.observer/filing/0001549595-26-000028.txt

## Key facts
- Shareholder Votes
  Nurix Therapeutics, Inc. shareholders approved Election of three Class III directors at the 2026-05-15 meeting.
  - Proposal: director election
  - Outcome: passed
  - Meeting: 2026-05-15
  source text: Nominee Votes For Votes Withheld Broker Non-Votes Arthur T. Sands, M.D., Ph.D. 63,592,948 16,334,570 3,819,495 Roger Dansey, M.D. 79,607,489 320,029 3,819,495 Paul M. Silva 59,298,612 20,628,906 3,819,495
  evidence_url: https://www.sec.gov/Archives/edgar/data/1549595/000154959526000028/0001549595-26-000028-index.htm
- Shareholder Votes
  Nurix Therapeutics, Inc. shareholders approved Ratification of appointment of PricewaterhouseCoopers LLP as independent registered public accounting firm for fiscal year ending November 30, 2026 at the 2026-05-15 meeting.
  - Proposal: auditor ratification
  - Outcome: passed
  - Meeting: 2026-05-15
  source text: Votes For Votes Against Abstentions Broker Non-Votes 83,555,977 166,391 24,645 —
  evidence_url: https://www.sec.gov/Archives/edgar/data/1549595/000154959526000028/0001549595-26-000028-index.htm
- Shareholder Votes
  Nurix Therapeutics, Inc. shareholders approved Approval, on a non-binding advisory basis, of the compensation of the Company's named executive officers at the 2026-05-15 meeting.
  - Proposal: say on pay
  - Outcome: passed
  - Meeting: 2026-05-15
  source text: Votes For Votes Against Abstentions Broker Non-Votes 72,458,920 6,895,394 573,204 3,819,495
  evidence_url: https://www.sec.gov/Archives/edgar/data/1549595/000154959526000028/0001549595-26-000028-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.